Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation

Transplantation

Volumn 90, Issue 12, 2010, Pages 1516-1520

  Li, Li ^a   Chaudhuri, Abanti ^a   Chen, Amery ^a   Zhao, Xinmeng ^a   Bezchinsky, Maria ^a   Concepcion, Waldo ^a   Salvatierra Jr , Oscar ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Daclizumab; Kidney transplantation; Pediatric nephrology; Steroid free immunosuppression protocol; Thymoglobulin

Indexed keywords

DACLIZUMAB; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; STEROID; SULFAMETHOXAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM; VALGANCICLOVIR;

ADOLESCENT; ARTICLE; BONE MARROW SUPPRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MALE; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; VIREMIA; VIRUS REPLICATION;

ANTILYMPHOCYTE SERUM; BIOPSY; CHILD; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT;

EID: 78650837441     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fc8937     Document Type: Article

References (18)

1. SarwalMM,VidhunJR, Alexander SR, et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003; 76: 1331.
2. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13.
3. Li L, Chang A, Naesens M, et al. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant 2009; 9: 1362.
4. Padiyar A, Augustine JJ, Bodziak KA, et al. Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. Transplant Proc 2010; 42: 1643.
5. Nainani N, Singh N, Shanahan T, et al. Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute antibody mediated rejection. Transpl Immunol 2009; 20: 113.
6. Pirsch JD, Ploeg RJ, Gange S, et al. Determinants of graft survival after renal transplantation. Transplantation 1996; 61: 1581.
7. Castro MC, Araujo LM, Nahas WC, et al. Induction versus noninduction therapy in kidney transplantation: Considering different PRA levels and different induction therapies. Transplant Proc 2004; 36: 874.
8. Cherikh WS, KauffmanHM,McBride MA, et al. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003; 76: 1289.
9. Matas AJ, Kandaswamy R, Gillingham KJ, et al. Prednisone-free maintenance immunosuppression -A 5-year experience. Am J Transplant 2005; 5: 2473.
10. Ault BH, Honaker MR, Osama Gaber A, et al. Short-term outcomes of thymoglobulin induction in pediatric renal transplant recipients. Pediatr Nephrol 2002; 17: 815.
11. Li L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007; 11: 187.
12. Schwartz GJ, Haycock GB, EdelmannCMJr, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259.
13. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106: 522.
14. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984; 104: 849.
15. Webster AC, Playford EG, Higgins G, et al. Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials. Transplantation 2004; 77: 166.
16. Szczech LA, Berlin JA, Aradhye S, et al. Effect of anti-lymphocyte induction therapy on renal allograft survival: A meta-analysis. J Am Soc Nephrol 1997; 8: 1771.
17. Lopez M, Clarkson MR, Albin M, et al.Anovel mechanism of action for anti-thymocyte globulin: Induction of CD4-CD25-Foxp3- regulatory T cells. J Am Soc Nephrol 2006; 17: 2844.
18. Kirk AD, Cherikh WS, Ring M, et al. Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant 2007; 7: 2619.